Document:

EX-10.1

 Exhibit 10.1 

THIRD AMENDMENT 
 TO THE
PULMATRIX, INC. AMENDED AND RESTATED 2013 EMPLOYEE, 
 DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN 

This THIRD AMENDMENT TO THE PULMATRIX, INC. AMENDED AND RESTATED 2013 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN (this
“Amendment”), dated as of September 6, 2019, is made and entered into by Pulmatrix, Inc., a Delaware corporation (the “Company”), subject to approval by the Company’s stockholders. Terms used in
this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan (the
“Incentive Plan”). 
 RECITALS 

WHEREAS, the Company sponsors and maintains the Incentive Plan in order to attract and retain the services of key employees, consultants, and directors
of the Company and its affiliates; 
 WHEREAS, Section 32 of the Incentive Plan permits the Board of Directors of the Company (the
“Board”) to amend the Incentive Plan at any time; 
 WHEREAS, upon the adoption of the Incentive Plan, subject to adjustment,
the Company initially reserved a total of 6,853,319 shares of its Common Stock to be issued pursuant to awards under the Incentive Plan; 
 WHEREAS,
on June 15, 2015, the Company effected a 1-for-2.5 reverse stock split of its issued and outstanding Common Stock such that, after giving effect to the reverse
stock split and other adjustments, there were 2,713,261 shares of Common Stock initially reserved for issuance under the Incentive Plan; 
 WHEREAS,
in accordance with the “evergreen” provision in the Incentive Plan, the number of shares of Common Stock reserved for issuance under the Incentive Plan was automatically increased on January 1, 2016, January 1, 2017, and
January 1, 2018 by 737,288 shares, 742,526 shares, and 903,600 shares, respectively, for a total of 5,096,675 shares reserved for issuance under the Incentive Plan; 

WHEREAS, effective as of June 5, 2018, the First Amendment to the Incentive Plan increased the aggregate number of shares of common stock that are
reserved and may be delivered pursuant to awards under the Incentive Plan by an additional 7,403,325 shares, for an aggregate maximum total of 12,500,000 shares available under the Incentive Plan; 

WHEREAS, in accordance with the “evergreen” provision in the Incentive Plan, on January 1, 2019, the number of shares of Common Stock
reserved for issuance under the Incentive Plan was automatically increased by 2,466,370 shares for a total of 14,966,370 shares reserved for issuance under the Incentive Plan; 

WHEREAS, on February 5, 2019, the Company effected a 1-for-10
reverse stock split of its issued and outstanding common stock such that, after giving effect to the reverse stock split and other adjustments, there were 1,496,637 shares of common stock reserved for issuance under the Incentive Plan; 

WHEREAS, effective as of March 11, 2019, the Company adopted the Second Amendment to the Incentive Plan, which did not materially modify the
Incentive Plan or affect the shares of common stock reserved for issuance thereunder; and 

 WHEREAS, the Board desires to amend the Incentive Plan to increase the aggregate number of shares of
Common Stock that are reserved and may be delivered pursuant to awards under the Incentive Plan by an additional 2,563,363 shares, for an aggregate maximum total of 4,060,000 shares available under the Incentive Plan (on a post-split basis); and

 WHEREAS, as of the date hereof, the Board resolved that this Amendment be adopted and that the Incentive Plan be amended as set forth herein. 

NOW, THEREFORE, in accordance with Section 32 of the Incentive Plan, and subject to the approval of the Company’s stockholders, the Company
hereby amends the Incentive Plan, effective as of the date hereof, as follows: 
 1. Subsection 3(a) of the Incentive Plan is hereby
amended by deleting said subsection in its entirety and substituting in lieu thereof the following new Subsection 3(a): 

(a) The number of Shares which may be issued from time to time pursuant to this Plan shall be 4,060,000, or the equivalent of
such number of Shares after the Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with Paragraph 25 of the Plan. ISOs may be
issued for up to 4,060,000 Shares issuable pursuant to the Plan. 
 2. Except as expressly amended by this Amendment, the Incentive Plan
shall continue in full force and effect in accordance with the provisions thereof. 
 * * * * * * * * 

  
 2 

 IN WITNESS WHEREOF, the Company has caused this Amendment to be duly executed as of the date first
written above. 
  

			
	PULMATRIX, INC.

 
			
		
	By:	 	 /s/ William Duke, Jr.

	Name:	 	 William Duke, Jr.

	Title:	 	 Chief Financial Officer

  
 Signature Page
to the Third Amendment to the 
 Pulmatrix, Inc. Amended and Restated 

2013 Employee, Director and Consultant Incentive PlanExhibit 10.1

 

 

 

September __, 2019

 

Dear Shubh Goel (“Employee”):

 

On behalf of the Board of Directors of Fennec Pharmaceuticals,
Inc. (“Fennec” or the “Company”), I am pleased to make you an executable offer to join the
Company as its Chief Commercial Officer. The purpose of this agreement is to clarify the terms of Employee’s “at will”
employment with the Company, including Employee’s compensation level and benefit entitlements.

 

1.    Employment and Duties.

 

A. The Company hereby agrees to employ Employee as Chief Commercial
Officer (“CCO”) of the Company and its parent corporation, Fennec Pharmaceuticals Inc. (the “Parent”),
effective as of September __, 2019 (the “Effective Date”). In that position, Employee will report directly to
the Company’s Chief Executive Officer, and Employee hereby agrees to accept such employment upon the terms and conditions
hereinafter set forth.

 

B. Employee will perform the duties inherent in Employee’s
position in good faith and in a reasonable and appropriate manner. Employee will be based out of Employee’s home office and/or
a Company office in New Jersey or New York City, but will be expected to travel from time to time as reasonably necessary or advisable
to perform and fulfil Employee’s responsibilities under this Agreement.

 

C. Employee shall be employed by the Company on an “at
will” basis, meaning either the Company or Executive may terminate Employee’s employment at any time, with or without
cause or advance notice except as specifically set forth in Section 8 of this Agreement. Any contrary representations that may
have been made to Employee shall be superseded by this Agreement. This Agreement (inclusive of the Proprietary Information and
Inventions Agreement incorporated herein) shall constitute the full and complete agreement between Employee and the Company on
the “at will” nature of Employee’s employment with the Company, which may be changed only in an express written
agreement signed by Employee and a duly authorized officer of the Company.

 

2.    Compensation.

 

A. Employee’s initial base salary will be at the rate
of $360,000 per year. Employee’s base salary will be subject to adjustment by the Company's Board of Directors on an annual
basis.

 

B. Employee shall
be entitled to receive an annual discretionary bonus with a target (the “Target Bonus”) of forty percent (40%)
of Employee’s base salary per 12-month period (which may be pro-rated for any partial period of less than 12 months),
based upon a determination by the CEO and, where applicable, the Company’s Board of Directors (the “Board”)
of the achievement of objectives to be set from time to time by the Board, provided that Employee must remain employed through
the payment date in order to earn the bonus. The measurement period for this purpose will end on approximately December 31 of each
year. For the avoidance of doubt, Employee may be entitled to receive the full Target Bonus for the year ending December 31, 2019.
The annual discretionary bonus, if otherwise earned subject to continued employment through the payment date, will be paid as soon
as practicable after the achievement of objectives for the measurement period has been determined, but in no event will such bonus
be paid after March 31 for the preceding measurement period. The Company may modify Employee’s compensation and
benefits from time to time at its sole discretion.

 

     

     

    

 

C. Employee’s base salary will be paid at periodic intervals
in accordance with the Company's payroll practices for salaried employees. The Company will deduct and withhold, from the base
salary and bonuses payable to Employee hereunder, any and all applicable Federal, state and local income and employment withholding
taxes and any other amounts required to be deducted or withheld by the Company under applicable statute or regulation.

 

3.    Employee Stock Options.

 

A. Upon execution of this Agreement, Fennec will grant Employee
175,000 options to purchase common shares (the “Equity Options”). The Equity Options shall: (i) have an exercise
price per share equal to the “Fair Market Value” (as defined in Plan); (ii) have a term of ten years and one-third
of which shall vest one year after the date of the grant and the balance thereof shall vest monthly thereafter for two years in
equal increments, and (iii) be otherwise on the terms and conditions set forth in the Plan;

B. At the discretion of the Company’s Board of Directors,
Employee may be granted stock option awards in addition to the Equity Options described in 3(A).

4.    Expense Reimbursement. Employee
will be entitled to reimbursement from the Company for all customary, ordinary and necessary business expenses incurred by Employee
in the performance of Employee’s duties hereunder in accordance with the Company policies, provided Employee furnish the
Company with vouchers, receipts and other details of such expenses within ninety (90) days after they are incurred.

 

5.    Fringe Benefits. Employee
will be eligible to participate in any group life insurance plan, group medical and/or dental insurance plan, accidental death
and dismemberment plan, short-term disability program and other employee benefit plans, including any Section 401(k) plan or employee
stock purchase plan if and when established, which are made available to executive officers of the Company and for which Employee
otherwise qualify.

 

6.    Vacation. Employee will
accrue 3 weeks of paid vacation benefits per year in accordance with the Company policy in effect for executive officers.

 

7.    Proprietary Information. 
Prior to commencement of Employee’s services as CCO, Employee will sign and deliver to the Company the standard-form Proprietary
Information and Inventions Agreement required of all key employees of the Company.

 

8.    Termination
of Employment.

 

A. Employee’s employment shall commence as of the Effective
Date and shall continue until terminated in accordance with this Agreement.

 

 

    	Goel Employment Contract	Page 2 of 5	 

     

    

 

B. The Company may terminate Employee’s employment under
this agreement at any time for any reason by providing Employee with at least thirty (30) days prior written notice. However, such
notice requirement is not required if Employee’s employment is terminated for cause as described in subparagraph 8(D) below.

 

C. If Employee’s employment is terminated by the Company
(other than for cause) pursuant to Subsection 8(B) or by the Employee for “good reason” pursuant to Subsection 8(F),
and such termination is not for any of the reasons set out in Subsections 8(D), then, following such termination, Employee shall
be entitled to continue to receive the following as severance (the "Severance Benefits"):

 

(i) an amount equal to:

 

(x) three (3) months of Employee’s
Base Salary, or

 

(y) if such termination occurs either (a) after the
second anniversary of the Effective Date or (b) as a result of a Change of Control as defined in 8F, six (6) months of Employee’s
Base Salary,

 

in either case, minus any federal, state and local payroll taxes
and other withholdings legally required or properly requested by Employee. The applicable foregoing amount shall be paid to Employee
in full within five (5) days of termination.

 

(ii) a pro rata share of any Target Bonus earned by Employee
for the year in which the termination takes place, minus any federal, state and local payroll taxes and other withholdings legally
required or properly requested by Employee; and

 

(iii) acceleration of vesting of stock options as a result of
such termination;

 

provided, however, Employee shall receive no Severance
Benefits under this Paragraph 8(C) unless Employee executes and delivers to the Company, in a form acceptable to the Company and
its counsel, a general release of claims against the Company (a “Release”), which Release is not revoked within
any time period allowed for revocation under applicable law.

 

D. The Company may at any time, upon written notice, terminate
Employee’s employment hereunder for cause as described in (i) and (ii) below. Such termination will be effective immediately
upon such notice and, for the avoidance of doubt, Employee will not be entitled to any Severance Benefits, nor any acceleration
of vesting of stock options, as a result of such termination.

 

For purposes of this agreement, Employee’s employment
with the Company will be deemed to have been involuntarily terminated for cause if Employee’s services are terminated by
the Company for one or more of the following reasons:

 

(i)       acts of fraud or
embezzlement or other intentional misconduct which materially adversely affects the Company's business, or

 

    	Goel Employment Contract	Page 3 of 5	 

     

    

 

(ii)       misappropriation
or unauthorized disclosure or use of the Company's proprietary information.

 

E. Employee’s employment shall automatically terminate
in the event of Employee’s death or permanent disability on the date of her death or permanent disability, as applicable.
However, all the Severance Benefits described in Section 8(C) shall be extended to Employee or Employee's beneficiaries, as applicable,
for a period of 12 months. “Permanent disability” in this context means that the Company in good faith has determined,
and advised Employee in writing that, the Employee has become incapacitated or disabled in a manner that indefinitely precludes
Employee from performing the essential functions of her position with the Company without any reasonable prospect of improvement,
and no reasonable accommodations can be made by the Company for Employee to return to work and perform such essential functions.

 

F. Employee may terminate his employment under this agreement
at any time for any reason upon thirty (30) days prior written notice to the Company. Company may, in its discretion, waive all
or any portion of such notice in writing. No Severance Benefits (including acceleration of vesting of stock options) are payable
to Employee unless such termination by Employee is for “good reason”. If the Employee terminates his employment for
"good reason", the Employee is entitled to receive the Severance Benefits described in Section 8(C) and acceleration
of vesting of stock options as a result of such termination. "Good reason" means: (i) a material decrease in the
Employee’s title, duties, responsibilities, and/or compensation and benefits; (ii) the Company requiring Employee to be based
out of any office more than 25 miles from Employee’s home office in New Jersey or New York City (for the avoidance of doubt,
the foregoing shall not apply to travel that is reasonably necessary or advisable from time to time for Employee to perform and
fulfil her responsibilities under this Agreement); (iii) the Company’s material breach of the employment agreement that has
not been cured within seven (7) days after Employee provides written notice of such material breach; (iv) the Parent completes
a transaction that constitutes a Change of Control and, in connection therewith or at any time within one (l) year following such
Change of Control, any of Employee’s title, duties, responsibilities, base salary or reporting structure have materially
changed. “Change of Control” shall have the meaning given to such term in the Parent’s stock option plan.

 

9. Governing Law. This agreement shall be
governed by and construed according to the laws of the State of North Carolina, without reference to the choice of law or conflict
of law provisions of such laws.

 

10. Entire Agreement. This agreement (inclusive
of the Proprietary Information and Inventions Agreement incorporated herein) contains the entire agreement and understanding by
and between the Company and Employee with respect to the terms described herein, and any representations, promises, agreements
or understandings, written or oral, not herein contained shall be of no force or effect. No change or modification hereof shall
be valid or binding unless the same is in writing and signed by the parties hereto.

Please indicate your acceptance of the foregoing provisions
of this employment agreement by signing the enclosed copy of this agreement and returning it to the Company.

 

    	Goel Employment Contract	Page 4 of 5	 

     

    

 

 

 

	 	Very truly yours,
	 	 
	 	Fennec Pharmaceuticals, Inc.
	 	 
	 	By:	 
	 	Name: Rostislav Raykov
	 	Title: Chief Executive Officer

 

 

 

	 ACCEPTED BY AND AGREED TO	 
	 	 
	 	 
	Shubh Goel	 
	 	 
	Dated: September __, 2019	 

 

 

 

 

 

    	Goel Employment Contract	Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]